Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital

Objective: To verify an association between weight and use of medications that lead to weight gain (MLGP) in a population of obese patients monitored in the Unified Health System. Methods: This is a retrospective descriptive sectional study with data from medical records of all patients. patients t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Layse A. SOUZA, Allan C. ARAÚJO, Ligiane L. SILVA, Poliana S. MENOLLI
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/c81c9cff3645463ba8b034ec2ec188fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c81c9cff3645463ba8b034ec2ec188fa
record_format	dspace
spelling	oai:doaj.org-article:c81c9cff3645463ba8b034ec2ec188fa2021-11-28T02:45:08ZWeight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital10.30968/rbfhss.2020.111.03642179-59242316-7750https://doaj.org/article/c81c9cff3645463ba8b034ec2ec188fa2020-07-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/364https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: To verify an association between weight and use of medications that lead to weight gain (MLGP) in a population of obese patients monitored in the Unified Health System. Methods: This is a retrospective descriptive sectional study with data from medical records of all patients. patients treated by the University Hospital Multiprofessional Service for obese patients who are candidates for bariatric surgery. The collection took place from January 2014 to March 2016. A weight-dependent variable, used in the body mass index (BMI) and degree of obesity and as independent variables of sex, age, education, income, number of diseases, number of drugs and number of MLGP. The association was calculated using the Ro Spearman correlation and the chi-square test. Results: 102 patients were studied, mostly women (87%), with a mean BMI of 45.9 kg / m2 (min 32.56 - maximum 70.98 kg / m2 SD = 6.43). The main comorbidities were systemic arterial hypertension (65.7%) and osteoarticular disorders (39.2%). The average number of drugs per patient was 4.3 and the most used class was for the renin-angiotensin system (67.3%). MLGP corresponds to 10.4% of the drugs used and 27.4% of the patients use them. MLGP patients used an average of 5.8 medications and the most prevalent classes were betablocking agents (60.6%), followed by medications used in diabetes (24.2%). Atenolol and a glibenclamide were the most used MLGP. The mean BMI of patients who used more than one MLGP was 51 kg / m2. Conclusion: There was no correlation between weight and the use of MLGP in this population. However, patients who used the MLGP combination had a higher BMI. Layse A. SOUZAAllan C. ARAÚJOLigiane L. SILVAPoliana S. MENOLLISociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 11, Iss 1 (2020)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Layse A. SOUZA Allan C. ARAÚJO Ligiane L. SILVA Poliana S. MENOLLI Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
description	Objective: To verify an association between weight and use of medications that lead to weight gain (MLGP) in a population of obese patients monitored in the Unified Health System. Methods: This is a retrospective descriptive sectional study with data from medical records of all patients. patients treated by the University Hospital Multiprofessional Service for obese patients who are candidates for bariatric surgery. The collection took place from January 2014 to March 2016. A weight-dependent variable, used in the body mass index (BMI) and degree of obesity and as independent variables of sex, age, education, income, number of diseases, number of drugs and number of MLGP. The association was calculated using the Ro Spearman correlation and the chi-square test. Results: 102 patients were studied, mostly women (87%), with a mean BMI of 45.9 kg / m2 (min 32.56 - maximum 70.98 kg / m2 SD = 6.43). The main comorbidities were systemic arterial hypertension (65.7%) and osteoarticular disorders (39.2%). The average number of drugs per patient was 4.3 and the most used class was for the renin-angiotensin system (67.3%). MLGP corresponds to 10.4% of the drugs used and 27.4% of the patients use them. MLGP patients used an average of 5.8 medications and the most prevalent classes were betablocking agents (60.6%), followed by medications used in diabetes (24.2%). Atenolol and a glibenclamide were the most used MLGP. The mean BMI of patients who used more than one MLGP was 51 kg / m2. Conclusion: There was no correlation between weight and the use of MLGP in this population. However, patients who used the MLGP combination had a higher BMI.
format	article
author	Layse A. SOUZA Allan C. ARAÚJO Ligiane L. SILVA Poliana S. MENOLLI
author_facet	Layse A. SOUZA Allan C. ARAÚJO Ligiane L. SILVA Poliana S. MENOLLI
author_sort	Layse A. SOUZA
title	Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
title_short	Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
title_full	Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
title_fullStr	Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
title_full_unstemmed	Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
title_sort	weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2020
url	https://doaj.org/article/c81c9cff3645463ba8b034ec2ec188fa
work_keys_str_mv	AT layseasouza weightgainingmedicationsusedbypatientsfollowedupatthebariatricandmetabolicsurgeryserviceofauniversityhospital AT allancaraujo weightgainingmedicationsusedbypatientsfollowedupatthebariatricandmetabolicsurgeryserviceofauniversityhospital AT ligianelsilva weightgainingmedicationsusedbypatientsfollowedupatthebariatricandmetabolicsurgeryserviceofauniversityhospital AT polianasmenolli weightgainingmedicationsusedbypatientsfollowedupatthebariatricandmetabolicsurgeryserviceofauniversityhospital
_version_	1718408465490116608

Weight-gaining medications used by patients followed up at the bariatric and metabolic surgery service of a university hospital

Ejemplares similares